ArticleFrontiers in pharmacology2025

Dihydroartemisinin targets the miR-497-5p/SOX5 axis to suppress tumor progression in non-small cell lung cancer.

Qing-Hua Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.